分层纤维斑块是心脏移植物血管病的主要成分:OCT系统发现与风险分层
研究纳入62例心脏移植患者,于常规血管造影时行OCT检查,前瞻性随访至2016年5月27日,分析172支血管的斑块成分与随访期间非致死性CAV进展的关系。结果显示分层纤维斑块是最常见斑块成分,其范围及亮斑范围均为非致死性CAV进展的强预测因子,联合两者可构建强预测模型。
要点
- 分层纤维斑块是心脏移植物血管病中最常见的斑块成分,其范围随造影CAV严重程度增加而增大。
- 分层纤维斑块范围与非致死性CAV进展强相关,风险比5.0(95%CI 2.1-12.4,P<0.0001)。
- 亮斑范围与非致死性CAV进展强相关,风险比6.2(95%CI 2.4-15.8,P<0.001)。
核心结论
- OCT可检测CAV相关斑块成分,实现造影不可见血管壁疾病的早期发现与鉴别;分层纤维斑块是最常见斑块成分,与非致死性CAV进展强相关,可能与小血栓机化导致的阶梯式CAV进展相关。
研究设计与样本
- 前瞻性研究,纳入62例心脏移植后于2013年9月至2015年10月行常规血管造影的患者,OCT采集尽可能长的回撤包括所有3支主要血管近段,随访至2016年5月27日。
关键影像表现/征象
- 分层纤维斑块是最常见的斑块成分,其范围随造影CAV严重程度增加而增大(P<0.01)。
- 172支血管中无CAV 111支、轻至中度CAV(狭窄<70%)40支、重度CAV(狭窄≥70%)21支。
- 随访期间172支血管中22支(13%)发生非致死性CAV进展,中位随访633天(四分位距432至808天)。
诊断标准与关键数值
- 非致死性CAV进展包括血管闭塞、新发严重(≥70%)造影冠状动脉狭窄或经皮冠状动脉介入治疗。
- 分层纤维斑块范围预测非致死性CAV进展:风险比5.0(95%CI 2.1-12.4,P<0.0001)。
- 亮斑范围预测非致死性CAV进展:风险比6.2(95%CI 2.4-15.8,P<0.001)。
- 联合分层纤维斑块与亮斑预测非致死性CAV进展:风险比8.9(95%CI 2.6-29.9,P<0.0001)。
临床应用与阅片要点
- OCT可检测CAV相关斑块成分,并实现造影不可见血管壁疾病的早期发现与鉴别。
- 分层纤维斑块范围及亮斑范围可用于非致死性CAV进展的风险分层。
- 联合分层纤维斑块与亮斑可构建强预测模型,辅助识别高危血管。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aims of this study were to characterize cardiac allograft vasculopathy (CAV) phenotypes using optical coherence tomography (OCT) and to evaluate the prognostic significance of OCT-determined CAV severity.
BACKGROUND: Intravascular OCT enables in vivo characterization of CAV microstructure after heart transplantation.
METHODS: Sixty-two patients undergoing heart transplantation were enrolled at routine angiography from September 2013 through October 2015 and prospectively followed until censoring on May 27, 2016. Optical coherence tomographic acquisitions aimed for the longest possible pull-backs, including proximal segments of all 3 major vessels. Plaques and bright spots were analyzed by delineating circumferential borders and measuring the angulation of total circumference. Layers were contoured for absolute and relative estimates. Nonfatal CAV progression (NFCP) during follow-up was registered. NFCP included occluded vessels or severe (≥70%) new angiographic coronary stenosis or percutaneous coronary intervention.
RESULTS: A total of 172 vessels were categorized as follows: no CAV, n = 111; mild to moderate CAV (<70% stenosis), n = 40; and severe CAV (≥70% stenosis), n = 21. Layered fibrotic plaque (LFP) was the most prevalent plaque component, and the extent increased with angiographic CAV severity (p < 0.01). During follow-up, 22 of 172 vessels (13%) experienced NFCP. Median follow-up was 633 days (interquartile range: 432 to 808 days). The extent of LFP (hazard ratio: 5.0; 95% confidence interval: 2.1 to 12.4; p < 0.0001) and the extent of bright spots (hazard ratio: 6.2; 95% confidence interval: 2.4 to 15.8, p < 0.001) were strong predictors of NFCP. By combining LFP and bright spots, a strong NFCP predictive model was obtained (hazard ratio: 8.9; 95% confidence interval: 2.6 to 29.9; p < 0.0001).
CONCLUSIONS: OCT enables the detection of CAV-associated plaque compositions and allows early detection and differentiation of vessel wall disease not visible on angiography. LFP was the most prevalent plaque component, was strongly associated with NFCP, and may be associated with stepwise CAV progression caused by organizing mural thrombi. (The GRAFT Study: Evaluation of Graft Function, Rejection and Cardiac Allograft Vasculopathy in First Heart Transplant Recipients; NCT02077764).
引用
- Clemmensen TS, Holm NR, Eiskjær H, et al. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT. JACC Cardiovasc Imaging. 2017. PMID: 28330670. doi:10.1016/j.jcmg.2016.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。